Wanbangde Pharmaceutical Holding Group Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 738.56 million compared to CNY 731.17 million a year ago. Net income was CNY 31.59 million compared to CNY 57.19 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0515 compared to CNY 0.0926 a year ago. Diluted earnings per share from continuing operations was CNY 0.0515 compared to CNY 0.0926 a year ago.